β-グルカン市場:供給源(穀類、キノコ、酵母、海藻)、用途(食品・飲料、パーソナルケア、医薬品、栄養補助食品、動物飼料)、地域(北米、欧州、APAC、中南米、RoW)別 - 2028年までの世界予測Beta-Glucan Market by Source (Cereal, Mushroom, Yeast and Seaweed), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement, Animal Feed), and Region (North America, Europe, APAC, Latin America and RoW) - Global Forecast to 2028 ベータグルカン市場は、2023年の501 Million USDから2028年には734 Million USDに成長すると予測され、予測期間中のCAGRは7.9%に達するとされています。この市場は、食品・飲料製品における天然添加物の使用需要... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーベータグルカン市場は、2023年の501 Million USDから2028年には734 Million USDに成長すると予測され、予測期間中のCAGRは7.9%に達するとされています。この市場は、食品・飲料製品における天然添加物の使用需要の増加、食物繊維を多く含む健康的な食生活の増加、健康上の利点があるβ-グルカンの受容率の上昇によって成長すると予測されています。このような要因により、β-グルカンの新製品を開発・展開する必要性が高まっています。D2023年には、穀物・シリアルというセグメントが最大のシェアを占めると予想されています。 穀物および穀類は、他の食品源と比較してβ-グルカンの含有量が比較的高いことで知られています。例えば、オーツ麦と大麦は特に高いレベルのβ-グルカンを含み、オーツ麦は最も豊富な食物源の一つです。穀類に含まれるβ-グルカンは、一般的に混合結合型であり、免疫調整作用やコレステロール低下作用など、健康に好ましい効果があることが示されている。穀類に含まれるβ-グルカンの含有量は高く、この有益な化合物を抽出するための望ましい供給源となる。 アプリケーション分野では、予測期間中、食品・飲料分野が市場を支配すると予測されています。 用途別では、予測期間中、食品・飲料分野が市場を支配すると予測されています。健康的な食生活に対する消費者の意識の高まり、ベーカリー、チューインガム、ミルク・タンパク質飲料、インスタント飲料などでのβ-グルカンの使用が、β-グルカンの採用につながっています。 2023年には、アジア太平洋地域が最も速い市場シェアを占めると予想されています。 ベータグルカン市場産業は、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、その他の地域で調査されています。2023-2028年の予測期間中、アジア太平洋地域が最も速い市場を占めています。中国やインドなどのアジア太平洋諸国では原材料が容易に入手できること、健康的な食品消費パターンの増加、日本や韓国などの国々では化粧品の使用が増加していることから、アジア太平洋市場は今後数年間でかなりの成長を遂げると考えられます。 β-グルカン市場の主要参入企業のプロファイルのブレークアップ: - バリューチェーン別:製造業者-85%、供給業者-15 - 役職別CXO:33.7%、マネージャー:44%、エグゼクティブ:22.3 - 地域別北米:60%、欧州:18%、アジア太平洋地域:10%、南米:8%、その他の地域:4 主な企業は、Tate & Lyle PLC(英国)、Kerry Group PLC(アイルランド)、Koninklijke DSM NV(オランダ)、International Flavors & Fragrances INC.(米国)、Merck(米国)です。 調査対象範囲です: この調査レポートは、βグルカン市場を供給源(穀物・穀類、キノコ、酵母、海藻)、カテゴリー(水溶性、不溶性)、用途(食品・飲料、パーソナルケア、医薬品、栄養補助食品、動物飼料)、地域(北米、欧州、アジア太平洋、南米、その他の地域)で分類しています。本レポートの範囲は、β-グルカン市場の成長に影響を与える推進要因、阻害要因、課題、機会などの主要要因に関する詳細情報をカバーしています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、協定、新製品・サービスの発表、M&A、脱石油レシチン市場に関連する最近の動向に関する洞察を提供しています。脱石油レシチン市場のエコシステムにおける今後の新興企業の競争力分析も本レポートでカバーしています。 本レポートを購入する理由 本レポートは、β-グルカン市場全体とサブセグメントの収益数値の最も近い近似値に関する情報を提供し、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争環境を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立つでしょう。また、市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報をステークホルダーに提供するのに役立ちます。 本レポートは、以下のポイントに関する洞察を提供します: - βグルカン市場の成長に影響を与える主要な促進要因(消費者の健康意識の高まりと健康支出の増加、異なる産業におけるβグルカンの用途の拡大)、抑制要因(βグルカンを管理する規制基準の不一致)、機会(未開発のβグルカン用途)、課題(消費者の認識不足)の分析。 - 製品開発/イノベーション:βグルカン市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細なインサイトを提供します。 - 市場開発:有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域のβ-グルカン市場を分析しています。 - 市場の多様化:βグルカン市場における新製品・サービス、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。 - 競争力評価:ベータグルカン市場戦略におけるTate & Lyle PLC(英国)、Kerry Group PLC(アイルランド)、Koninklijke DSM NV(オランダ)、International Flavors & Fragrances INC.(米国)、Merck(米国)などの主要企業の市場シェア、成長戦略、サービス提供について詳しく評価します。また、本レポートは、スターターカルチャー市場を理解し、主要な市場促進要因、阻害要因、課題、および機会に関する情報を関係者に提供します。 目次1 INTRODUCTION 331.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 STUDY SCOPE 34 FIGURE 1 MARKET SEGMENTATION 34 1.3.1 INCLUSIONS & EXCLUSIONS 34 1.4 REGIONS COVERED 35 1.5 PERIODIZATION CONSIDERED 35 1.6 UNITS CONSIDERED 36 1.6.1 CURRENCY CONSIDERED 36 TABLE 1 USD EXCHANGE RATES, 2017–2022 36 1.6.2 VOLUME UNIT CONSIDERED 37 1.7 STAKEHOLDERS 37 1.8 SUMMARY OF CHANGES 37 1.8.1 RECESSION IMPACT ANALYSIS 38 2 RESEARCH METHODOLOGY 39 2.1 RESEARCH DATA 39 FIGURE 2 BETA GLUCAN MARKET: RESEARCH DESIGN 39 2.1.1 SECONDARY DATA 40 2.1.1.1 Key data from secondary sources 40 2.1.2 PRIMARY DATA 41 2.1.2.1 Key data from primary sources 41 2.1.2.2 Key industry insights 41 2.1.2.3 Breakdown of primaries 42 2.2 MARKET SIZE ESTIMATION 43 2.2.1 APPROACH ONE: TOP-DOWN 43 FIGURE 3 BETA-GLUCAN MARKET SIZE ESTIMATION – TOP-DOWN APPROACH 43 2.2.2 APPROACH TWO: BOTTOM-UP 44 FIGURE 4 BETA-GLUCAN MARKET SIZE ESTIMATION – BOTTOM-UP APPROACH 44 2.3 DATA TRIANGULATION 45 FIGURE 5 DATA TRIANGULATION METHODOLOGY 45 2.4 STUDY ASSUMPTIONS 46 2.5 STUDY LIMITATIONS 47 2.6 RECESSION IMPACT ON BETA-GLUCAN MARKET 47 2.6.1 MACROECONOMIC INDICATORS OF RECESSION 47 FIGURE 6 INDICATORS OF RECESSION 48 FIGURE 7 GLOBAL INFLATION RATE, 2011–2021 48 FIGURE 8 GLOBAL GDP, 2011–2021 (USD TRILLION) 49 FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET 50 FIGURE 10 BETA-GLUCAN MARKET: PREVIOUS FORECAST VS. RECESSION FORECAST 50 3 EXECUTIVE SUMMARY 52 FIGURE 11 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 53 FIGURE 12 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION) 53 FIGURE 13 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 54 FIGURE 14 BETA-GLUCAN MARKET SNAPSHOT, BY REGION 54 4 PREMIUM INSIGHTS 56 4.1 BRIEF OVERVIEW OF BETA-GLUCAN MARKET 56 FIGURE 15 GROWTH IN HEALTH-CONSCIOUS POPULATION TO DRIVE BETA-GLUCAN MARKET 56 4.2 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE & COUNTRY 57 FIGURE 16 GRAINS & CEREALS AND US DOMINATED RESPECTIVE SEGMENTS IN NORTH AMERICAN MARKET IN 2022 57 4.3 BETA-GLUCAN MARKET, BY APPLICATION & REGION 57 FIGURE 17 FOOD & BEVERAGE SEGMENT DOMINATED MARKET ACROSS ALL REGIONS IN 2022 (USD MILLION) 57 4.4 BETA-GLUCAN MARKET, BY KEY COUNTRY 58 FIGURE 18 CHINA AND INDIA TO BE MOST LUCRATIVE MARKETS FOR BETA-GLUCAN 58 4.5 BETA-GLUCAN MARKET, BY CATEGORY 59 FIGURE 19 NORTH AMERICA TO DOMINATE BETA-GLUCAN MARKET AMONG ALL REGIONS THROUGH FORECAST PERIOD 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MACROECONOMIC INDICATORS 60 5.2.1 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES 60 FIGURE 20 NUMBER OF NEW CANCER CASES FOR ALL AGES, 2015–2020 (MILLION) 61 5.2.2 INCREASE IN CONSUMPTION OF DIETARY FIBERS 61 5.3 MARKET DYNAMICS 62 FIGURE 21 MARKET DYNAMICS: BETA-GLUCAN MARKET 62 5.3.1 DRIVERS 62 5.3.1.1 Growth in health consciousness among consumers and increasing health expenditure 62 FIGURE 22 INCREASING PER CAPITA HEALTH EXPENDITURE IN MAJOR ECONOMIES, 2015–2019 (USD) 63 5.3.1.2 Increase in application of beta-glucan in different industries 63 5.3.2 RESTRAINTS 64 5.3.2.1 Inconsistency in regulatory norms governing beta-glucan 64 5.3.2.2 Price volatility of raw materials 64 5.3.3 OPPORTUNITIES 65 5.3.3.1 Untapped beta-glucan applications 65 5.3.3.2 Rise in demand for natural and plant-based ingredients 65 5.3.4 CHALLENGES 66 5.3.4.1 Lack of consumer awareness regarding benefits specific to beta-glucan 66 6 INDUSTRY TRENDS 67 6.1 INTRODUCTION 67 6.2 VALUE CHAIN ANALYSIS 67 6.2.1 RESEARCH & DEVELOPMENT AND RAW MATERIAL SOURCING 67 6.2.2 MANUFACTURING 67 6.2.3 DISTRIBUTION 67 6.2.4 END USERS 68 FIGURE 23 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS 68 6.3 SUPPLY CHAIN 68 FIGURE 24 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS 68 6.3.1 SMOOTH PROCUREMENT OF RAW MATERIALS 69 6.3.2 DISTRIBUTION CHANNELS TO REDUCE DEMAND-SUPPLY GAP 69 6.4 TECHNOLOGY ANALYSIS 69 6.4.1 ENCAPSULATION 69 6.4.2 NEW AVENUES OF YEAST CULTURE & EXTRACTION 70 6.5 BETA-GLUCAN MARKET MAP AND ECOSYSTEM 70 6.5.1 DEMAND SIDE 70 6.5.2 SUPPLY SIDE 70 FIGURE 25 BETA-GLUCAN MARKET: ECOSYSTEM MAP 71 6.5.3 ECOSYSTEM MAP 71 TABLE 2 BETA-GLUCAN MARKET ECOSYSTEM 71 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72 6.6.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN BETA-GLUCAN MARKET 72 FIGURE 26 REVENUE SHIFT IMPACTING TRENDS/DISRUPTIONS IN BETA-GLUCAN MARKET 72 6.7 PATENT ANALYSIS 73 FIGURE 27 PATENT ANALYSIS FOR BETA-GLUCAN MARKET, 2012–2022 73 FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN, 2012–2022 74 6.7.1 LIST OF MAJOR PATENTS 74 6.8 PORTER’S FIVE FORCES ANALYSIS 76 6.8.1 THREAT OF NEW ENTRANTS 76 6.8.2 THREAT OF SUBSTITUTES 76 6.8.3 BARGAINING POWER OF SUPPLIERS 76 6.8.4 BARGAINING POWER OF BUYERS 77 6.8.5 INTENSITY OF COMPETITIVE RIVALRY 77 6.9 CASE STUDY ANALYSIS 77 6.9.1 CARGILL, INC.: INVESTMENT OF USD 35 MILLION IN EUROPE 77 6.9.2 TATE & LYLE PLC: EXTENDING ITS DISTRIBUTION PARTNERSHIP 78 6.10 TARIFF AND REGULATORY LANDSCAPE 78 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 6.10.1.1 North America 78 TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 6.10.1.2 Europe 79 TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 6.10.1.3 Asia Pacific 80 TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 6.10.1.4 RoW 80 TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 6.11 REGULATIONS 81 6.11.1 INTRODUCTION 81 6.11.2 NORTH AMERICA 81 6.11.2.1 US Food and Drug Administration (21CFR101.14) 81 6.11.2.2 US Food and Drug Administration (21CFR101.81) 81 6.11.3 EUROPEAN FOOD SAFETY AUTHORITY 81 6.11.4 EUROPEAN UNION 81 6.12 KEY STAKEHOLDERS IN BUYING PROCESS 82 6.12.1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 82 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 82 TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 82 6.12.2 BUYING CRITERIA 83 FIGURE 30 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS 83 TABLE 8 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS 83 7 BETA-GLUCAN MARKET, BY SOURCE 84 7.1 INTRODUCTION 85 FIGURE 31 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 85 TABLE 9 BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 86 TABLE 10 BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 86 TABLE 11 BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 86 TABLE 12 BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 86 7.2 CEREALS & GRAINS 87 TABLE 13 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 87 TABLE 14 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 87 TABLE 15 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018–2022 (TON) 88 TABLE 16 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023–2028 (TON) 88 7.2.1 OATS 88 7.2.1.1 Increase in awareness of health benefits of beta-glucan from oats 88 7.2.2 BARLEY 89 7.2.2.1 Diverse applications of barley-based beta-glucan in various industries 89 7.2.3 OTHER SOURCES 89 7.3 MUSHROOM 90 7.3.1 D-GLUCAN FROM MUSHROOMS CATERS TO GROWTH IN DEMAND FOR IMMUNE SYSTEM-SUPPORTING INGREDIENTS 90 TABLE 17 MUSHROOM SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 90 TABLE 18 MUSHROOM SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 90 TABLE 19 MUSHROOM SOURCES MARKET, BY REGION, 2018–2022 (TON) 91 TABLE 20 MUSHROOM SOURCES MARKET, BY REGION, 2023–2028 (TON) 91 7.4 YEAST 91 7.4.1 GOVERNMENT SUPPORT FOR RESEARCH & DEVELOPMENT ON YEAST-BASED BETA-GLUCAN 91 TABLE 21 YEAST SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 92 TABLE 22 YEAST SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 92 TABLE 23 YEAST SOURCES MARKET, BY REGION, 2018–2022 (TON) 93 TABLE 24 YEAST SOURCES MARKET, BY REGION, 2023–2028 (TON) 93 7.5 SEAWEED 93 7.5.1 GROWING USE OF SEAWEED-BASED BETA-GLUCAN IN COSMETIC AND PERSONAL CARE PRODUCTS 93 TABLE 25 SEAWEED SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 94 TABLE 26 SEAWEED SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 94 TABLE 27 SEAWEED SOURCES MARKET, BY REGION, 2018–2022 (TON) 94 TABLE 28 SEAWEED SOURCES MARKET, BY REGION, 2023–2028 (TON) 95 8 BETA-GLUCAN MARKET, BY CATEGORY 96 8.1 INTRODUCTION 97 FIGURE 32 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION) 97 TABLE 29 BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 97 TABLE 30 GLOBAL BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 97 8.2 SOLUBLE BETA-GLUCAN 98 8.2.1 RISE IN PREVALENCE OF CHRONIC LIFESTYLE DISEASES 98 TABLE 31 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 98 TABLE 32 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 99 8.3 INSOLUBLE BETA-GLUCAN 99 8.3.1 POSITIVE EFFECTS OF INSOLUBLE BETA-GLUCAN ON HUMAN HEALTH 99 TABLE 33 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 100 TABLE 34 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 100 9 BETA-GLUCAN MARKET, BY TYPE 101 9.1 INTRODUCTION 101 9.2 1,3 BETA-GLUCAN 101 9.3 1,4 BETA-GLUCAN 101 9.4 1,6 BETA-GLUCAN 102 10 BETA-GLUCAN MARKET, BY APPLICATION 103 10.1 INTRODUCTION 104 TABLE 35 APPLICATION OVERVIEW 104 FIGURE 33 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 105 TABLE 36 BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 105 TABLE 37 BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 105 10.2 FOOD & BEVERAGES 106 10.2.1 BENEFITS OF DIET INCLUDING SOLUBLE FIBER IN MANAGING CHRONIC CONDITIONS 106 TABLE 38 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 106 TABLE 39 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 106 10.3 PERSONAL CARE 107 10.3.1 CONSUMERS’ DEMAND FOR NATURAL AND HEALTH INGREDIENTS IN PERSONAL CARE PRODUCTS 107 TABLE 40 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 107 TABLE 41 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 108 10.4 PHARMACEUTICALS 108 10.4.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS 108 TABLE 42 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 109 TABLE 43 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 109 10.5 DIETARY SUPPLEMENTS 109 10.5.1 INCREASE IN AWARENESS OF ASSOCIATED HEALTH BENEFITS 109 TABLE 44 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 110 TABLE 45 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 110 10.6 ANIMAL FEED 111 10.6.1 GROWING INCLINATION OF PET AND LIVESTOCK OWNERS TOWARD NUTRITIOUS FEED 111 TABLE 46 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 111 TABLE 47 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 112 11 BETA-GLUCAN MARKET, BY BRAND 113 11.1 INTRODUCTION 113 11.2 OATWELL 113 11.3 PROMOAT 113 11.4 SANACEL 113 11.5 AVENACARE 113 11.6 NUTRIM 113 11.7 WELLMUNE 114 11.8 YESTIMUN 114 12 BETA-GLUCAN MARKET, BY EXTRACTION METHOD 115 12.1 INTRODUCTION 115 TABLE 48 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES 115 12.2 BETA-GLUCAN FROM CEREAL 116 12.3 BETA-GLUCAN FROM YEAST 116 13 BETA-GLUCAN MARKET, BY REGION 117 13.1 INTRODUCTION 118 FIGURE 34 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2023–2028 119 TABLE 49 GLOBAL BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 119 TABLE 50 BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 120 TABLE 51 BETA-GLUCAN MARKET, BY REGION, 2018–2022 (TON) 120 TABLE 52 BETA-GLUCAN MARKET, BY REGION, 2023–2028 (TON) 120 13.2 NORTH AMERICA 121 FIGURE 35 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT 122 13.2.1 NORTH AMERICA: RECESSION IMPACT 122 FIGURE 36 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2021 123 FIGURE 37 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 124 TABLE 53 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 124 TABLE 54 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 125 TABLE 55 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 125 TABLE 56 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 125 TABLE 57 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 126 TABLE 58 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 126 TABLE 59 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 126 TABLE 60 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 126 TABLE 61 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 127 TABLE 62 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 127 13.2.2 US 127 13.2.2.1 Rise in awareness and consumption of fiber-rich ingredient-based products 127 TABLE 63 US: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 128 TABLE 64 US: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 128 TABLE 65 US: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 128 TABLE 66 US: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 129 13.2.3 CANADA 129 13.2.3.1 Increased potential usage in food & beverage and pharmaceutical applications in Canada 129 TABLE 67 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 130 TABLE 68 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 130 TABLE 69 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 130 TABLE 70 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 130 13.2.4 MEXICO 131 13.2.4.1 Support from government initiatives and public healthcare campaigns 131 TABLE 71 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 131 TABLE 72 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 131 TABLE 73 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 132 TABLE 74 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 132 13.3 EUROPE 132 13.3.1 EUROPE: RECESSION IMPACT 133 FIGURE 38 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2021 134 FIGURE 39 EUROPE: RECESSION IMPACT ANALYSIS, 2023 134 TABLE 75 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 135 TABLE 76 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 135 TABLE 77 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 135 TABLE 78 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 136 TABLE 79 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 136 TABLE 80 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 136 TABLE 81 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 137 TABLE 82 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 137 TABLE 83 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 137 TABLE 84 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 138 13.3.2 GERMANY 138 13.3.2.1 Rise in prevalence of diabetes and population inclining toward natural ingredient-based foods 138 TABLE 85 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 138 TABLE 86 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 139 TABLE 87 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 139 TABLE 88 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 139 13.3.3 FRANCE 139 13.3.3.1 Demand for functional foods in France 139 TABLE 89 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 140 TABLE 90 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 140 TABLE 91 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 140 TABLE 92 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 141 13.3.4 UK 141 13.3.4.1 Growth in natural ingredient trend in UK 141 TABLE 93 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 142 TABLE 94 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 142 TABLE 95 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 142 TABLE 96 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 142 13.3.5 ITALY 143 13.3.5.1 Significant rise in consumer demand for health-enriching ingredients in Italy 143 TABLE 97 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 143 TABLE 98 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 143 TABLE 99 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 144 TABLE 100 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 144 13.3.6 SPAIN 144 13.3.6.1 Rise in consumer awareness toward consumption of organic ingredients 144 TABLE 101 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 145 TABLE 102 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 145 TABLE 103 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 145 TABLE 104 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 146 13.3.7 REST OF EUROPE 146 TABLE 105 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 146 TABLE 106 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 147 TABLE 107 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 147 TABLE 108 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 147 13.4 ASIA PACIFIC 147 13.4.1 ASIA PACIFIC: RECESSION IMPACT 148 FIGURE 40 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2021 149 FIGURE 41 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023 150 FIGURE 42 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT 151 TABLE 109 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 151 TABLE 110 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 152 TABLE 111 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 152 TABLE 112 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 152 TABLE 113 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 153 TABLE 114 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 153 TABLE 115 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 153 TABLE 116 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 153 TABLE 117 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 154 TABLE 118 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 154 13.4.2 CHINA 154 13.4.2.1 Rise in preference for fortified products in China 154 TABLE 119 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 155 TABLE 120 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 155 TABLE 121 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 156 TABLE 122 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 156 13.4.3 INDIA 156 13.4.3.1 Innovation and product development in beta-glucan industry in India 156 TABLE 123 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 157 TABLE 124 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 157 TABLE 125 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 157 TABLE 126 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 157 13.4.4 JAPAN 158 13.4.4.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures in Japan 158 TABLE 127 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 158 TABLE 128 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 158 TABLE 129 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 159 TABLE 130 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 159 13.4.5 AUSTRALIA & NEW ZEALAND 159 13.4.5.1 High spending capacity on nutritional products in ANZ 159 TABLE 131 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 160 TABLE 132 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 160 TABLE 133 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 160 TABLE 134 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 161 13.4.6 REST OF ASIA PACIFIC 161 TABLE 135 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 161 TABLE 136 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 162 TABLE 137 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 162 TABLE 138 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 162 13.5 SOUTH AMERICA 163 13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 163 FIGURE 43 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2021 164 FIGURE 44 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 164 TABLE 139 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 165 TABLE 140 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 165 TABLE 141 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 165 TABLE 142 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 166 TABLE 143 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 166 TABLE 144 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 166 TABLE 145 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 167 TABLE 146 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 167 TABLE 147 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 167 TABLE 148 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 167 13.5.2 BRAZIL 168 13.5.2.1 Development of food & beverage industry due to inflow of FDI 168 TABLE 149 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 168 TABLE 150 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 168 TABLE 151 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 169 TABLE 152 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 169 13.5.3 ARGENTINA 169 13.5.3.1 Increase in consumer awareness regarding health benefits of beta-glucan in Argentina 169 FIGURE 45 ARGENTINA: HEALTH EXPENDITURE (SHARE OF GDP), 2012–2017 170 TABLE 153 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 170 TABLE 154 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 170 TABLE 155 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 171 TABLE 156 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 171 13.5.4 REST OF SOUTH AMERICA 171 TABLE 157 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 172 TABLE 158 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 172 TABLE 159 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 172 TABLE 160 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 173 13.6 REST OF THE WORLD (ROW) 173 13.6.1 ROW: RECESSION IMPACT 173 FIGURE 46 ROW: INFLATION RATES, BY KEY COUNTRY, 2017–2021 174 FIGURE 47 ROW: RECESSION IMPACT ANALYSIS, 2023 175 TABLE 161 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 175 TABLE 162 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 176 TABLE 163 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 176 TABLE 164 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 176 TABLE 165 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 177 TABLE 166 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 177 TABLE 167 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 177 TABLE 168 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 177 TABLE 169 ROW: BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 178 TABLE 170 ROW: BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 178 13.6.2 MIDDLE EAST 178 13.6.2.1 Increased health and wellness initiatives in Middle East 178 TABLE 171 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 179 TABLE 172 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 179 TABLE 173 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 179 TABLE 174 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 179 13.6.3 AFRICA 180 13.6.3.1 Growing demand for natural and functional ingredients in Africa 180 TABLE 175 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 180 TABLE 176 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 180 TABLE 177 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 181 TABLE 178 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 181 14 COMPETITIVE LANDSCAPE 182 14.1 OVERVIEW 182 14.2 MARKET SHARE ANALYSIS 182 TABLE 179 BETA-GLUCAN MARKET: DEGREE OF COMPETITION (FRAGMENTED), 2022 183 14.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 183 FIGURE 48 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2018–2022 (USD MILLION) 183 14.4 STRATEGIES ADOPTED BY KEY PLAYERS 184 TABLE 180 STRATEGIES ADOPTED BY KEY BETA-GLUCAN MANUFACTURERS 184 14.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 186 14.5.1 STARS 187 14.5.2 EMERGING LEADERS 187 14.5.3 PERVASIVE PLAYERS 187 14.5.4 PARTICIPANTS 187 FIGURE 49 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (KEY PLAYERS) 188 14.5.5 PRODUCT FOOTPRINT 189 TABLE 181 COMPANY FOOTPRINT, BY SOURCE 189 TABLE 182 COMPANY FOOTPRINT, BY APPLICATION 190 TABLE 183 COMPANY FOOTPRINT, BY REGION 191 TABLE 184 OVERALL COMPANY FOOTPRINT 192 14.6 COMPANY EVALUATION QUADRANT (STARTUPS/SMES) 193 14.6.1 PROGRESSIVE COMPANIES 193 14.6.2 STARTING BLOCKS 193 14.6.3 RESPONSIVE COMPANIES 193 14.6.4 DYNAMIC COMPANIES 193 FIGURE 50 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (STARTUPS/SMES) 194 14.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 195 TABLE 185 BETA-GLUCAN MARKET: DETAILED LIST OF KEY STARTUPS/SMES 195 TABLE 186 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 196 14.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 197 14.7.1 PRODUCT LAUNCHES 197 14.7.2 DEALS 197 TABLE 187 BETA-GLUCAN MARKET: DEALS, 2018–2022 197 14.7.3 OTHER DEVELOPMENTS 200 TABLE 188 BETA-GLUCAN MARKET: OTHER DEVELOPMENTS, 2018–2022 200 15 COMPANY PROFILES 204 15.1 KEY PLAYERS 204 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 15.1.1 TATE & LYLE PLC 204 TABLE 189 TATE & LYLE PLC: BUSINESS OVERVIEW 204 FIGURE 51 TATE & LYLE PLC: COMPANY SNAPSHOT 205 TABLE 190 TATE & LYLE PLC: PRODUCTS OFFERED 205 TABLE 191 TATE & LYLE PLC: DEALS 206 TABLE 192 TATE & LYLE PLC: OTHER DEVELOPMENTS 206 15.1.2 KERRY GROUP PLC 208 TABLE 193 KERRY GROUP PLC: BUSINESS OVERVIEW 208 FIGURE 52 KERRY GROUP PLC: COMPANY SNAPSHOT 209 TABLE 194 KERRY GROUP PLC: PRODUCTS OFFERED 209 15.1.3 KONINKLIJKE DSM N.V. 211 TABLE 195 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 211 FIGURE 53 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 212 TABLE 196 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 212 TABLE 197 KONINKLIJKE DSM N.V.: OTHER DEVELOPMENTS 213 15.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC. 214 TABLE 198 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 214 FIGURE 54 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 215 TABLE 199 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED 215 TABLE 200 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 216 TABLE 201 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS 216 15.1.5 MERCK 218 TABLE 202 MERCK: BUSINESS OVERVIEW 218 FIGURE 55 MERCK: COMPANY SNAPSHOT 219 TABLE 203 MERCK: PRODUCTS OFFERED 219 TABLE 204 MERCK: OTHER DEVELOPMENTS 220 15.1.6 LESAFFRE HUMAN CARE 222 TABLE 205 LESAFFRE HUMAN CARE: BUSINESS OVERVIEW 222 TABLE 206 LESAFFRE HUMAN CARE: PRODUCTS OFFERED 222 TABLE 207 LESAFFRE HUMAN CARE: DEALS 223 15.1.7 KEMIN INDUSTRIES 225 TABLE 208 KEMIN INDUSTRIES: BUSINESS OVERVIEW 225 TABLE 209 KEMIN INDUSTRIES: PRODUCTS OFFERED 225 TABLE 210 KEMIN INDUSTRIES OTHER DEVELOPMENTS 226 15.1.8 ANGEL YEAST CO., LTD 227 TABLE 211 ANGEL YEAST CO., LTD: BUSINESS OVERVIEW 227 FIGURE 56 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT 227 TABLE 212 ANGEL YEAST CO., LTD: PRODUCTS OFFERED 228 15.1.9 LALLEMAND 230 TABLE 213 LALLEMAND: BUSINESS OVERVIEW 230 TABLE 214 LALLEMAND: PRODUCTS OFFERED 230 TABLE 215 LALLEMAND: DEALS 231 15.1.10 OHLY GMBH 232 TABLE 216 OHLY GMBH: BUSINESS OVERVIEW 232 TABLE 217 OHLY GMBH: PRODUCTS OFFERED 232 15.1.11 BIORIGIN - ZILOR 234 TABLE 218 BIORIGIN - ZILOR: BUSINESS OVERVIEW 234 TABLE 219 BIORIGIN - ZILOR: PRODUCTS OFFERED 234 15.1.12 CEAPRO INC. 236 TABLE 220 CEAPRO INC: BUSINESS OVERVIEW 236 FIGURE 57 CEAPRO INC.: COMPANY SNAPSHOT 237 TABLE 221 CEAPRO INC: PRODUCT OFFERED 238 TABLE 222 CEAPRO INC: DEALS 238 TABLE 223 CEAPRO INC: OTHER DEVELOPMENTS 239 15.1.13 SPECIALTY BIOTECH CO., LTD. 240 TABLE 224 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW 240 TABLE 225 SPECIALTY BIOTECH CO., LTD.: PRODUCTS OFFERED 240 15.1.14 ALLTECH LIFE SCIENCES 241 TABLE 226 ALLTECH LIFE SCIENCES: BUSINESS OVERVIEW 241 TABLE 227 ALLTECH LIFE SCIENCES: PRODUCTS OFFERED 241 15.1.15 GLYCONOVA 243 TABLE 228 GLYCONOVA: BUSINESS OVERVIEW 243 TABLE 229 GLYCONOVA: PRODUCTS OFFERED 243 15.1.16 GARUDA INTERNATIONAL INC. 245 TABLE 230 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW 245 15.1.17 VAN WANKUM INGREDIENTS 247 TABLE 231 VAN WANKUM INGREDIENTS: BUSINESS OVERVIEW 247 TABLE 232 VAN WANKUM INGREDIENTS: PRODUCTS OFFERED 247 15.1.18 SUPER BETA GLUCAN 249 TABLE 233 SUPER BETA GLUCAN: BUSINESS OVERVIEW 249 TABLE 234 SUPER BETA GLUCAN: PRODUCTS OFFERED 249 15.1.19 LEIBER GROUP GMBH & CO KG 251 TABLE 235 LEIBER GROUP GMBH & CO KG: BUSINESS OVERVIEW 251 TABLE 236 LEIBER GROUP GMBH & CO KG: PRODUCTS OFFERED 251 15.1.20 NUTRISCIENCE INNOVATIONS 253 TABLE 237 NUTRISCIENCE INNOVATIONS: BUSINESS OVERVIEW 253 TABLE 238 NUTRISCIENCE INNOVATIONS: PRODUCTS OFFERED 253 15.1.21 EMBRIA HEALTH SCIENCES LLC 254 15.1.22 NUTRAQ 254 15.1.23 ABAC R&D AG 255 15.1.24 GLUCAN CORPORATION 255 15.1.25 TRANSFER POINT, INC. 256 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 16 ADJACENT & RELATED MARKETS 257 16.1 INTRODUCTION 257 TABLE 239 ADJACENT MARKETS 257 16.2 STUDY LIMITATIONS 257 16.3 FEED FLAVORS AND SWEETENERS MARKET 257 16.3.1 MARKET DEFINITION 257 16.3.2 MARKET OVERVIEW 257 TABLE 240 FEED SWEETENERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 258 TABLE 241 FEED SWEETENERS MARKET, BY TYPE, 2015–2022 (KT) 258 16.4 STARTER CULTURE MARKET 259 16.4.1 MARKET DEFINITION 259 16.4.2 MARKET OVERVIEW 259 TABLE 242 STARTER CULTURE MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 260 TABLE 243 STARTER CULTURE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 260 17 APPENDIX 261 17.1 DISCUSSION GUIDE 261 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 265 17.3 CUSTOMIZATION OPTIONS 267 17.4 AUTHOR DETAILS 268
SummaryThe beta-glucan market is projected to grow from USD 501 Million in 2023 to USD 734 Million by 2028, at a CAGR of 7.9% during the forecast period. The market is anticipated to grow due to increasing demand for use of natural additives in the food and beverage products, growing consumption of healthy diets with high fiber, rising surge in acceptance for beta-glucan for its several health-benefits. Such factors have driven the need to develop and deploy new products for beta-glucan. D Table of Contents1 INTRODUCTION 331.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 STUDY SCOPE 34 FIGURE 1 MARKET SEGMENTATION 34 1.3.1 INCLUSIONS & EXCLUSIONS 34 1.4 REGIONS COVERED 35 1.5 PERIODIZATION CONSIDERED 35 1.6 UNITS CONSIDERED 36 1.6.1 CURRENCY CONSIDERED 36 TABLE 1 USD EXCHANGE RATES, 2017–2022 36 1.6.2 VOLUME UNIT CONSIDERED 37 1.7 STAKEHOLDERS 37 1.8 SUMMARY OF CHANGES 37 1.8.1 RECESSION IMPACT ANALYSIS 38 2 RESEARCH METHODOLOGY 39 2.1 RESEARCH DATA 39 FIGURE 2 BETA GLUCAN MARKET: RESEARCH DESIGN 39 2.1.1 SECONDARY DATA 40 2.1.1.1 Key data from secondary sources 40 2.1.2 PRIMARY DATA 41 2.1.2.1 Key data from primary sources 41 2.1.2.2 Key industry insights 41 2.1.2.3 Breakdown of primaries 42 2.2 MARKET SIZE ESTIMATION 43 2.2.1 APPROACH ONE: TOP-DOWN 43 FIGURE 3 BETA-GLUCAN MARKET SIZE ESTIMATION – TOP-DOWN APPROACH 43 2.2.2 APPROACH TWO: BOTTOM-UP 44 FIGURE 4 BETA-GLUCAN MARKET SIZE ESTIMATION – BOTTOM-UP APPROACH 44 2.3 DATA TRIANGULATION 45 FIGURE 5 DATA TRIANGULATION METHODOLOGY 45 2.4 STUDY ASSUMPTIONS 46 2.5 STUDY LIMITATIONS 47 2.6 RECESSION IMPACT ON BETA-GLUCAN MARKET 47 2.6.1 MACROECONOMIC INDICATORS OF RECESSION 47 FIGURE 6 INDICATORS OF RECESSION 48 FIGURE 7 GLOBAL INFLATION RATE, 2011–2021 48 FIGURE 8 GLOBAL GDP, 2011–2021 (USD TRILLION) 49 FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET 50 FIGURE 10 BETA-GLUCAN MARKET: PREVIOUS FORECAST VS. RECESSION FORECAST 50 3 EXECUTIVE SUMMARY 52 FIGURE 11 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 53 FIGURE 12 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION) 53 FIGURE 13 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 54 FIGURE 14 BETA-GLUCAN MARKET SNAPSHOT, BY REGION 54 4 PREMIUM INSIGHTS 56 4.1 BRIEF OVERVIEW OF BETA-GLUCAN MARKET 56 FIGURE 15 GROWTH IN HEALTH-CONSCIOUS POPULATION TO DRIVE BETA-GLUCAN MARKET 56 4.2 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE & COUNTRY 57 FIGURE 16 GRAINS & CEREALS AND US DOMINATED RESPECTIVE SEGMENTS IN NORTH AMERICAN MARKET IN 2022 57 4.3 BETA-GLUCAN MARKET, BY APPLICATION & REGION 57 FIGURE 17 FOOD & BEVERAGE SEGMENT DOMINATED MARKET ACROSS ALL REGIONS IN 2022 (USD MILLION) 57 4.4 BETA-GLUCAN MARKET, BY KEY COUNTRY 58 FIGURE 18 CHINA AND INDIA TO BE MOST LUCRATIVE MARKETS FOR BETA-GLUCAN 58 4.5 BETA-GLUCAN MARKET, BY CATEGORY 59 FIGURE 19 NORTH AMERICA TO DOMINATE BETA-GLUCAN MARKET AMONG ALL REGIONS THROUGH FORECAST PERIOD 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MACROECONOMIC INDICATORS 60 5.2.1 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES 60 FIGURE 20 NUMBER OF NEW CANCER CASES FOR ALL AGES, 2015–2020 (MILLION) 61 5.2.2 INCREASE IN CONSUMPTION OF DIETARY FIBERS 61 5.3 MARKET DYNAMICS 62 FIGURE 21 MARKET DYNAMICS: BETA-GLUCAN MARKET 62 5.3.1 DRIVERS 62 5.3.1.1 Growth in health consciousness among consumers and increasing health expenditure 62 FIGURE 22 INCREASING PER CAPITA HEALTH EXPENDITURE IN MAJOR ECONOMIES, 2015–2019 (USD) 63 5.3.1.2 Increase in application of beta-glucan in different industries 63 5.3.2 RESTRAINTS 64 5.3.2.1 Inconsistency in regulatory norms governing beta-glucan 64 5.3.2.2 Price volatility of raw materials 64 5.3.3 OPPORTUNITIES 65 5.3.3.1 Untapped beta-glucan applications 65 5.3.3.2 Rise in demand for natural and plant-based ingredients 65 5.3.4 CHALLENGES 66 5.3.4.1 Lack of consumer awareness regarding benefits specific to beta-glucan 66 6 INDUSTRY TRENDS 67 6.1 INTRODUCTION 67 6.2 VALUE CHAIN ANALYSIS 67 6.2.1 RESEARCH & DEVELOPMENT AND RAW MATERIAL SOURCING 67 6.2.2 MANUFACTURING 67 6.2.3 DISTRIBUTION 67 6.2.4 END USERS 68 FIGURE 23 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS 68 6.3 SUPPLY CHAIN 68 FIGURE 24 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS 68 6.3.1 SMOOTH PROCUREMENT OF RAW MATERIALS 69 6.3.2 DISTRIBUTION CHANNELS TO REDUCE DEMAND-SUPPLY GAP 69 6.4 TECHNOLOGY ANALYSIS 69 6.4.1 ENCAPSULATION 69 6.4.2 NEW AVENUES OF YEAST CULTURE & EXTRACTION 70 6.5 BETA-GLUCAN MARKET MAP AND ECOSYSTEM 70 6.5.1 DEMAND SIDE 70 6.5.2 SUPPLY SIDE 70 FIGURE 25 BETA-GLUCAN MARKET: ECOSYSTEM MAP 71 6.5.3 ECOSYSTEM MAP 71 TABLE 2 BETA-GLUCAN MARKET ECOSYSTEM 71 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72 6.6.1 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN BETA-GLUCAN MARKET 72 FIGURE 26 REVENUE SHIFT IMPACTING TRENDS/DISRUPTIONS IN BETA-GLUCAN MARKET 72 6.7 PATENT ANALYSIS 73 FIGURE 27 PATENT ANALYSIS FOR BETA-GLUCAN MARKET, 2012–2022 73 FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN, 2012–2022 74 6.7.1 LIST OF MAJOR PATENTS 74 6.8 PORTER’S FIVE FORCES ANALYSIS 76 6.8.1 THREAT OF NEW ENTRANTS 76 6.8.2 THREAT OF SUBSTITUTES 76 6.8.3 BARGAINING POWER OF SUPPLIERS 76 6.8.4 BARGAINING POWER OF BUYERS 77 6.8.5 INTENSITY OF COMPETITIVE RIVALRY 77 6.9 CASE STUDY ANALYSIS 77 6.9.1 CARGILL, INC.: INVESTMENT OF USD 35 MILLION IN EUROPE 77 6.9.2 TATE & LYLE PLC: EXTENDING ITS DISTRIBUTION PARTNERSHIP 78 6.10 TARIFF AND REGULATORY LANDSCAPE 78 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 6.10.1.1 North America 78 TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 6.10.1.2 Europe 79 TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 6.10.1.3 Asia Pacific 80 TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 6.10.1.4 RoW 80 TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 6.11 REGULATIONS 81 6.11.1 INTRODUCTION 81 6.11.2 NORTH AMERICA 81 6.11.2.1 US Food and Drug Administration (21CFR101.14) 81 6.11.2.2 US Food and Drug Administration (21CFR101.81) 81 6.11.3 EUROPEAN FOOD SAFETY AUTHORITY 81 6.11.4 EUROPEAN UNION 81 6.12 KEY STAKEHOLDERS IN BUYING PROCESS 82 6.12.1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 82 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 82 TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS 82 6.12.2 BUYING CRITERIA 83 FIGURE 30 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS 83 TABLE 8 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS ACROSS TOP APPLICATIONS 83 7 BETA-GLUCAN MARKET, BY SOURCE 84 7.1 INTRODUCTION 85 FIGURE 31 BETA-GLUCAN MARKET, BY SOURCE, 2023 VS. 2028 (USD MILLION) 85 TABLE 9 BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 86 TABLE 10 BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 86 TABLE 11 BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 86 TABLE 12 BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 86 7.2 CEREALS & GRAINS 87 TABLE 13 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 87 TABLE 14 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 87 TABLE 15 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2018–2022 (TON) 88 TABLE 16 CEREAL & GRAIN SOURCES MARKET, BY REGION, 2023–2028 (TON) 88 7.2.1 OATS 88 7.2.1.1 Increase in awareness of health benefits of beta-glucan from oats 88 7.2.2 BARLEY 89 7.2.2.1 Diverse applications of barley-based beta-glucan in various industries 89 7.2.3 OTHER SOURCES 89 7.3 MUSHROOM 90 7.3.1 D-GLUCAN FROM MUSHROOMS CATERS TO GROWTH IN DEMAND FOR IMMUNE SYSTEM-SUPPORTING INGREDIENTS 90 TABLE 17 MUSHROOM SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 90 TABLE 18 MUSHROOM SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 90 TABLE 19 MUSHROOM SOURCES MARKET, BY REGION, 2018–2022 (TON) 91 TABLE 20 MUSHROOM SOURCES MARKET, BY REGION, 2023–2028 (TON) 91 7.4 YEAST 91 7.4.1 GOVERNMENT SUPPORT FOR RESEARCH & DEVELOPMENT ON YEAST-BASED BETA-GLUCAN 91 TABLE 21 YEAST SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 92 TABLE 22 YEAST SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 92 TABLE 23 YEAST SOURCES MARKET, BY REGION, 2018–2022 (TON) 93 TABLE 24 YEAST SOURCES MARKET, BY REGION, 2023–2028 (TON) 93 7.5 SEAWEED 93 7.5.1 GROWING USE OF SEAWEED-BASED BETA-GLUCAN IN COSMETIC AND PERSONAL CARE PRODUCTS 93 TABLE 25 SEAWEED SOURCES MARKET, BY REGION, 2018–2022 (USD MILLION) 94 TABLE 26 SEAWEED SOURCES MARKET, BY REGION, 2023–2028 (USD MILLION) 94 TABLE 27 SEAWEED SOURCES MARKET, BY REGION, 2018–2022 (TON) 94 TABLE 28 SEAWEED SOURCES MARKET, BY REGION, 2023–2028 (TON) 95 8 BETA-GLUCAN MARKET, BY CATEGORY 96 8.1 INTRODUCTION 97 FIGURE 32 BETA-GLUCAN MARKET, BY CATEGORY, 2023 VS. 2028 (USD MILLION) 97 TABLE 29 BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 97 TABLE 30 GLOBAL BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 97 8.2 SOLUBLE BETA-GLUCAN 98 8.2.1 RISE IN PREVALENCE OF CHRONIC LIFESTYLE DISEASES 98 TABLE 31 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 98 TABLE 32 SOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 99 8.3 INSOLUBLE BETA-GLUCAN 99 8.3.1 POSITIVE EFFECTS OF INSOLUBLE BETA-GLUCAN ON HUMAN HEALTH 99 TABLE 33 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 100 TABLE 34 INSOLUBLE BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 100 9 BETA-GLUCAN MARKET, BY TYPE 101 9.1 INTRODUCTION 101 9.2 1,3 BETA-GLUCAN 101 9.3 1,4 BETA-GLUCAN 101 9.4 1,6 BETA-GLUCAN 102 10 BETA-GLUCAN MARKET, BY APPLICATION 103 10.1 INTRODUCTION 104 TABLE 35 APPLICATION OVERVIEW 104 FIGURE 33 BETA-GLUCAN MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 105 TABLE 36 BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 105 TABLE 37 BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 105 10.2 FOOD & BEVERAGES 106 10.2.1 BENEFITS OF DIET INCLUDING SOLUBLE FIBER IN MANAGING CHRONIC CONDITIONS 106 TABLE 38 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 106 TABLE 39 BETA-GLUCAN MARKET IN FOOD & BEVERAGE APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 106 10.3 PERSONAL CARE 107 10.3.1 CONSUMERS’ DEMAND FOR NATURAL AND HEALTH INGREDIENTS IN PERSONAL CARE PRODUCTS 107 TABLE 40 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 107 TABLE 41 BETA-GLUCAN MARKET IN PERSONAL CARE APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 108 10.4 PHARMACEUTICALS 108 10.4.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS 108 TABLE 42 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 109 TABLE 43 BETA-GLUCAN MARKET IN PHARMACEUTICAL APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 109 10.5 DIETARY SUPPLEMENTS 109 10.5.1 INCREASE IN AWARENESS OF ASSOCIATED HEALTH BENEFITS 109 TABLE 44 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 110 TABLE 45 BETA-GLUCAN MARKET IN DIETARY SUPPLEMENT APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 110 10.6 ANIMAL FEED 111 10.6.1 GROWING INCLINATION OF PET AND LIVESTOCK OWNERS TOWARD NUTRITIOUS FEED 111 TABLE 46 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2018–2022 (USD MILLION) 111 TABLE 47 BETA-GLUCAN MARKET IN ANIMAL FEED APPLICATIONS, BY REGION, 2023–2028 (USD MILLION) 112 11 BETA-GLUCAN MARKET, BY BRAND 113 11.1 INTRODUCTION 113 11.2 OATWELL 113 11.3 PROMOAT 113 11.4 SANACEL 113 11.5 AVENACARE 113 11.6 NUTRIM 113 11.7 WELLMUNE 114 11.8 YESTIMUN 114 12 BETA-GLUCAN MARKET, BY EXTRACTION METHOD 115 12.1 INTRODUCTION 115 TABLE 48 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES 115 12.2 BETA-GLUCAN FROM CEREAL 116 12.3 BETA-GLUCAN FROM YEAST 116 13 BETA-GLUCAN MARKET, BY REGION 117 13.1 INTRODUCTION 118 FIGURE 34 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2023–2028 119 TABLE 49 GLOBAL BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 119 TABLE 50 BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 120 TABLE 51 BETA-GLUCAN MARKET, BY REGION, 2018–2022 (TON) 120 TABLE 52 BETA-GLUCAN MARKET, BY REGION, 2023–2028 (TON) 120 13.2 NORTH AMERICA 121 FIGURE 35 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT 122 13.2.1 NORTH AMERICA: RECESSION IMPACT 122 FIGURE 36 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2021 123 FIGURE 37 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 124 TABLE 53 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 124 TABLE 54 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 125 TABLE 55 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 125 TABLE 56 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 125 TABLE 57 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 126 TABLE 58 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 126 TABLE 59 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 126 TABLE 60 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 126 TABLE 61 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 127 TABLE 62 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 127 13.2.2 US 127 13.2.2.1 Rise in awareness and consumption of fiber-rich ingredient-based products 127 TABLE 63 US: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 128 TABLE 64 US: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 128 TABLE 65 US: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 128 TABLE 66 US: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 129 13.2.3 CANADA 129 13.2.3.1 Increased potential usage in food & beverage and pharmaceutical applications in Canada 129 TABLE 67 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 130 TABLE 68 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 130 TABLE 69 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 130 TABLE 70 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 130 13.2.4 MEXICO 131 13.2.4.1 Support from government initiatives and public healthcare campaigns 131 TABLE 71 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 131 TABLE 72 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 131 TABLE 73 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 132 TABLE 74 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 132 13.3 EUROPE 132 13.3.1 EUROPE: RECESSION IMPACT 133 FIGURE 38 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017–2021 134 FIGURE 39 EUROPE: RECESSION IMPACT ANALYSIS, 2023 134 TABLE 75 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 135 TABLE 76 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 135 TABLE 77 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 135 TABLE 78 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 136 TABLE 79 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 136 TABLE 80 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 136 TABLE 81 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 137 TABLE 82 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 137 TABLE 83 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 137 TABLE 84 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 138 13.3.2 GERMANY 138 13.3.2.1 Rise in prevalence of diabetes and population inclining toward natural ingredient-based foods 138 TABLE 85 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 138 TABLE 86 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 139 TABLE 87 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 139 TABLE 88 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 139 13.3.3 FRANCE 139 13.3.3.1 Demand for functional foods in France 139 TABLE 89 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 140 TABLE 90 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 140 TABLE 91 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 140 TABLE 92 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 141 13.3.4 UK 141 13.3.4.1 Growth in natural ingredient trend in UK 141 TABLE 93 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 142 TABLE 94 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 142 TABLE 95 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 142 TABLE 96 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 142 13.3.5 ITALY 143 13.3.5.1 Significant rise in consumer demand for health-enriching ingredients in Italy 143 TABLE 97 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 143 TABLE 98 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 143 TABLE 99 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 144 TABLE 100 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 144 13.3.6 SPAIN 144 13.3.6.1 Rise in consumer awareness toward consumption of organic ingredients 144 TABLE 101 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 145 TABLE 102 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 145 TABLE 103 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 145 TABLE 104 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 146 13.3.7 REST OF EUROPE 146 TABLE 105 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 146 TABLE 106 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 147 TABLE 107 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 147 TABLE 108 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 147 13.4 ASIA PACIFIC 147 13.4.1 ASIA PACIFIC: RECESSION IMPACT 148 FIGURE 40 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017–2021 149 FIGURE 41 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023 150 FIGURE 42 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT 151 TABLE 109 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 151 TABLE 110 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 152 TABLE 111 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 152 TABLE 112 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 152 TABLE 113 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 153 TABLE 114 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 153 TABLE 115 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 153 TABLE 116 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 153 TABLE 117 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 154 TABLE 118 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 154 13.4.2 CHINA 154 13.4.2.1 Rise in preference for fortified products in China 154 TABLE 119 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 155 TABLE 120 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 155 TABLE 121 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 156 TABLE 122 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 156 13.4.3 INDIA 156 13.4.3.1 Innovation and product development in beta-glucan industry in India 156 TABLE 123 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 157 TABLE 124 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 157 TABLE 125 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 157 TABLE 126 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 157 13.4.4 JAPAN 158 13.4.4.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures in Japan 158 TABLE 127 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 158 TABLE 128 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 158 TABLE 129 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 159 TABLE 130 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 159 13.4.5 AUSTRALIA & NEW ZEALAND 159 13.4.5.1 High spending capacity on nutritional products in ANZ 159 TABLE 131 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 160 TABLE 132 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 160 TABLE 133 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 160 TABLE 134 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 161 13.4.6 REST OF ASIA PACIFIC 161 TABLE 135 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 161 TABLE 136 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 162 TABLE 137 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 162 TABLE 138 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 162 13.5 SOUTH AMERICA 163 13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS 163 FIGURE 43 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017–2021 164 FIGURE 44 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023 164 TABLE 139 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 165 TABLE 140 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 165 TABLE 141 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 165 TABLE 142 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 166 TABLE 143 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 166 TABLE 144 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 166 TABLE 145 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 167 TABLE 146 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 167 TABLE 147 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 167 TABLE 148 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 167 13.5.2 BRAZIL 168 13.5.2.1 Development of food & beverage industry due to inflow of FDI 168 TABLE 149 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 168 TABLE 150 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 168 TABLE 151 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 169 TABLE 152 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 169 13.5.3 ARGENTINA 169 13.5.3.1 Increase in consumer awareness regarding health benefits of beta-glucan in Argentina 169 FIGURE 45 ARGENTINA: HEALTH EXPENDITURE (SHARE OF GDP), 2012–2017 170 TABLE 153 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 170 TABLE 154 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 170 TABLE 155 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 171 TABLE 156 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 171 13.5.4 REST OF SOUTH AMERICA 171 TABLE 157 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 172 TABLE 158 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 172 TABLE 159 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 172 TABLE 160 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 173 13.6 REST OF THE WORLD (ROW) 173 13.6.1 ROW: RECESSION IMPACT 173 FIGURE 46 ROW: INFLATION RATES, BY KEY COUNTRY, 2017–2021 174 FIGURE 47 ROW: RECESSION IMPACT ANALYSIS, 2023 175 TABLE 161 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 175 TABLE 162 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 176 TABLE 163 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (USD MILLION) 176 TABLE 164 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (USD MILLION) 176 TABLE 165 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2018–2022 (TON) 177 TABLE 166 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2023–2028 (TON) 177 TABLE 167 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 177 TABLE 168 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 177 TABLE 169 ROW: BETA-GLUCAN MARKET, BY REGION, 2018–2022 (USD MILLION) 178 TABLE 170 ROW: BETA-GLUCAN MARKET, BY REGION, 2023–2028 (USD MILLION) 178 13.6.2 MIDDLE EAST 178 13.6.2.1 Increased health and wellness initiatives in Middle East 178 TABLE 171 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 179 TABLE 172 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 179 TABLE 173 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 179 TABLE 174 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 179 13.6.3 AFRICA 180 13.6.3.1 Growing demand for natural and functional ingredients in Africa 180 TABLE 175 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2018–2022 (USD MILLION) 180 TABLE 176 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2023–2028 (USD MILLION) 180 TABLE 177 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 181 TABLE 178 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2023–2028 (USD MILLION) 181 14 COMPETITIVE LANDSCAPE 182 14.1 OVERVIEW 182 14.2 MARKET SHARE ANALYSIS 182 TABLE 179 BETA-GLUCAN MARKET: DEGREE OF COMPETITION (FRAGMENTED), 2022 183 14.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 183 FIGURE 48 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2018–2022 (USD MILLION) 183 14.4 STRATEGIES ADOPTED BY KEY PLAYERS 184 TABLE 180 STRATEGIES ADOPTED BY KEY BETA-GLUCAN MANUFACTURERS 184 14.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 186 14.5.1 STARS 187 14.5.2 EMERGING LEADERS 187 14.5.3 PERVASIVE PLAYERS 187 14.5.4 PARTICIPANTS 187 FIGURE 49 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (KEY PLAYERS) 188 14.5.5 PRODUCT FOOTPRINT 189 TABLE 181 COMPANY FOOTPRINT, BY SOURCE 189 TABLE 182 COMPANY FOOTPRINT, BY APPLICATION 190 TABLE 183 COMPANY FOOTPRINT, BY REGION 191 TABLE 184 OVERALL COMPANY FOOTPRINT 192 14.6 COMPANY EVALUATION QUADRANT (STARTUPS/SMES) 193 14.6.1 PROGRESSIVE COMPANIES 193 14.6.2 STARTING BLOCKS 193 14.6.3 RESPONSIVE COMPANIES 193 14.6.4 DYNAMIC COMPANIES 193 FIGURE 50 BETA-GLUCAN MARKET: COMPANY EVALUATION QUADRANT, 2023 (STARTUPS/SMES) 194 14.6.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 195 TABLE 185 BETA-GLUCAN MARKET: DETAILED LIST OF KEY STARTUPS/SMES 195 TABLE 186 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 196 14.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 197 14.7.1 PRODUCT LAUNCHES 197 14.7.2 DEALS 197 TABLE 187 BETA-GLUCAN MARKET: DEALS, 2018–2022 197 14.7.3 OTHER DEVELOPMENTS 200 TABLE 188 BETA-GLUCAN MARKET: OTHER DEVELOPMENTS, 2018–2022 200 15 COMPANY PROFILES 204 15.1 KEY PLAYERS 204 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 15.1.1 TATE & LYLE PLC 204 TABLE 189 TATE & LYLE PLC: BUSINESS OVERVIEW 204 FIGURE 51 TATE & LYLE PLC: COMPANY SNAPSHOT 205 TABLE 190 TATE & LYLE PLC: PRODUCTS OFFERED 205 TABLE 191 TATE & LYLE PLC: DEALS 206 TABLE 192 TATE & LYLE PLC: OTHER DEVELOPMENTS 206 15.1.2 KERRY GROUP PLC 208 TABLE 193 KERRY GROUP PLC: BUSINESS OVERVIEW 208 FIGURE 52 KERRY GROUP PLC: COMPANY SNAPSHOT 209 TABLE 194 KERRY GROUP PLC: PRODUCTS OFFERED 209 15.1.3 KONINKLIJKE DSM N.V. 211 TABLE 195 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 211 FIGURE 53 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 212 TABLE 196 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 212 TABLE 197 KONINKLIJKE DSM N.V.: OTHER DEVELOPMENTS 213 15.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC. 214 TABLE 198 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 214 FIGURE 54 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 215 TABLE 199 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED 215 TABLE 200 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 216 TABLE 201 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHER DEVELOPMENTS 216 15.1.5 MERCK 218 TABLE 202 MERCK: BUSINESS OVERVIEW 218 FIGURE 55 MERCK: COMPANY SNAPSHOT 219 TABLE 203 MERCK: PRODUCTS OFFERED 219 TABLE 204 MERCK: OTHER DEVELOPMENTS 220 15.1.6 LESAFFRE HUMAN CARE 222 TABLE 205 LESAFFRE HUMAN CARE: BUSINESS OVERVIEW 222 TABLE 206 LESAFFRE HUMAN CARE: PRODUCTS OFFERED 222 TABLE 207 LESAFFRE HUMAN CARE: DEALS 223 15.1.7 KEMIN INDUSTRIES 225 TABLE 208 KEMIN INDUSTRIES: BUSINESS OVERVIEW 225 TABLE 209 KEMIN INDUSTRIES: PRODUCTS OFFERED 225 TABLE 210 KEMIN INDUSTRIES OTHER DEVELOPMENTS 226 15.1.8 ANGEL YEAST CO., LTD 227 TABLE 211 ANGEL YEAST CO., LTD: BUSINESS OVERVIEW 227 FIGURE 56 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT 227 TABLE 212 ANGEL YEAST CO., LTD: PRODUCTS OFFERED 228 15.1.9 LALLEMAND 230 TABLE 213 LALLEMAND: BUSINESS OVERVIEW 230 TABLE 214 LALLEMAND: PRODUCTS OFFERED 230 TABLE 215 LALLEMAND: DEALS 231 15.1.10 OHLY GMBH 232 TABLE 216 OHLY GMBH: BUSINESS OVERVIEW 232 TABLE 217 OHLY GMBH: PRODUCTS OFFERED 232 15.1.11 BIORIGIN - ZILOR 234 TABLE 218 BIORIGIN - ZILOR: BUSINESS OVERVIEW 234 TABLE 219 BIORIGIN - ZILOR: PRODUCTS OFFERED 234 15.1.12 CEAPRO INC. 236 TABLE 220 CEAPRO INC: BUSINESS OVERVIEW 236 FIGURE 57 CEAPRO INC.: COMPANY SNAPSHOT 237 TABLE 221 CEAPRO INC: PRODUCT OFFERED 238 TABLE 222 CEAPRO INC: DEALS 238 TABLE 223 CEAPRO INC: OTHER DEVELOPMENTS 239 15.1.13 SPECIALTY BIOTECH CO., LTD. 240 TABLE 224 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW 240 TABLE 225 SPECIALTY BIOTECH CO., LTD.: PRODUCTS OFFERED 240 15.1.14 ALLTECH LIFE SCIENCES 241 TABLE 226 ALLTECH LIFE SCIENCES: BUSINESS OVERVIEW 241 TABLE 227 ALLTECH LIFE SCIENCES: PRODUCTS OFFERED 241 15.1.15 GLYCONOVA 243 TABLE 228 GLYCONOVA: BUSINESS OVERVIEW 243 TABLE 229 GLYCONOVA: PRODUCTS OFFERED 243 15.1.16 GARUDA INTERNATIONAL INC. 245 TABLE 230 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW 245 15.1.17 VAN WANKUM INGREDIENTS 247 TABLE 231 VAN WANKUM INGREDIENTS: BUSINESS OVERVIEW 247 TABLE 232 VAN WANKUM INGREDIENTS: PRODUCTS OFFERED 247 15.1.18 SUPER BETA GLUCAN 249 TABLE 233 SUPER BETA GLUCAN: BUSINESS OVERVIEW 249 TABLE 234 SUPER BETA GLUCAN: PRODUCTS OFFERED 249 15.1.19 LEIBER GROUP GMBH & CO KG 251 TABLE 235 LEIBER GROUP GMBH & CO KG: BUSINESS OVERVIEW 251 TABLE 236 LEIBER GROUP GMBH & CO KG: PRODUCTS OFFERED 251 15.1.20 NUTRISCIENCE INNOVATIONS 253 TABLE 237 NUTRISCIENCE INNOVATIONS: BUSINESS OVERVIEW 253 TABLE 238 NUTRISCIENCE INNOVATIONS: PRODUCTS OFFERED 253 15.1.21 EMBRIA HEALTH SCIENCES LLC 254 15.1.22 NUTRAQ 254 15.1.23 ABAC R&D AG 255 15.1.24 GLUCAN CORPORATION 255 15.1.25 TRANSFER POINT, INC. 256 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 16 ADJACENT & RELATED MARKETS 257 16.1 INTRODUCTION 257 TABLE 239 ADJACENT MARKETS 257 16.2 STUDY LIMITATIONS 257 16.3 FEED FLAVORS AND SWEETENERS MARKET 257 16.3.1 MARKET DEFINITION 257 16.3.2 MARKET OVERVIEW 257 TABLE 240 FEED SWEETENERS MARKET, BY TYPE, 2015–2022 (USD MILLION) 258 TABLE 241 FEED SWEETENERS MARKET, BY TYPE, 2015–2022 (KT) 258 16.4 STARTER CULTURE MARKET 259 16.4.1 MARKET DEFINITION 259 16.4.2 MARKET OVERVIEW 259 TABLE 242 STARTER CULTURE MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 260 TABLE 243 STARTER CULTURE MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 260 17 APPENDIX 261 17.1 DISCUSSION GUIDE 261 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 265 17.3 CUSTOMIZATION OPTIONS 267 17.4 AUTHOR DETAILS 268
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(食品)の最新刊レポート
MarketsandMarkets社のFood & Beverages分野での最新刊レポート
本レポートと同じKEY WORD(source)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|